The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Thursday, August 13, 2026

Subject of the day

NEOG

Concerning the House

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

United States · www.neogen.com

The Long Run

FY 2012–2025 · 14 years

LineLatestCAGRTrend
Revenue$924.22M+26.4%
Gross profit$421.38M+12.4%
Operating income$37.52M+0.8%
Net income-$1.09B+7.9%
Cash from ops$35.26M+4.7%
Quotation

$11.46

-0.03 (-0.3%)

52w hi$12.04
52w lo$5.23
Vol1.24M
As ofAug 12
The Verdict

Hold

Our score +0.21

Short+0.26
Medium+0.35
Long-0.16

computed 2026-08-12

By the Numbers

Neogen Corporation

Healthcare · Medical Devices

Market cap$2.50B
Enterprise value$3.13B
Trailing P/E
Forward P/E30.16x
EV / EBITDA33.08x
P / S (ttm)2.87x
Profit margin-0.9%
Return on equity-0.4%
Revenue growth-0.1%
Earnings growth
Debt / equity38.83
Risk Metrics
Beta vs SPX0.47
Corr SPX0.12
Annual vol62.1%
Annual ret+1.4%
Sharpe0.02
Max DD-75.0%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental-0.02
Sector+0.12
Technical+0.18
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-12

Recent Sessions
DateOpenHighLowCloseVol
Aug 12$11.49$11.61$11.30$11.461.24M
Aug 11$11.47$11.70$11.35$11.492.29M
Aug 10$11.32$11.49$11.21$11.401.62M
Aug 7$11.28$11.50$11.24$11.471.52M
Aug 6$11.45$11.62$11.15$11.302.29M